Best Tools for Gut Health & Weight Loss | Dr. Chris Thompson
Dr. Chris Thompson, a Harvard gastroenterologist and obesity medicine expert, discusses the mechanisms of gut health, hunger regulation, weight loss treatments including GLP-1 drugs and endoscopic procedures, and emerging therapies like gene therapy. He emphasizes early metabolic screening through tools like continuous glucose monitors and the importance of addressing underlying metabolic dysfunction rather than just symptoms.
Summary
This episode features an in-depth conversation between Andrew Huberman and Dr. Chris Thompson about gastrointestinal health, metabolism, and obesity treatment. Thompson begins by explaining the basic anatomy and function of the digestive system, from the esophagus through the colon, detailing how each organ compartment has specific roles in food processing and nutrient absorption. He emphasizes the critical importance of the gut microbiome and how fiber feeds beneficial bacteria to produce butyrate, which maintains tight junctions in the intestinal lining—if people don't consume enough fiber, their microbiome will consume the protective mucous layer instead.
The discussion moves into hunger and satiety mechanisms, covering key hormones including ghrelin (hunger hormone produced in the stomach fundus), CCK, peptide YY, and GLP-1, which are produced in response to meals and signal fullness to the brain. Thompson explains how the stomach stretches in anticipation of food (triggered by smell alone) and how this mechanical signal contributes to satiety signaling.
Regarding GLP-1 drugs (Ozempic, Wegovy, Mounjaro), Thompson acknowledges their effectiveness but notes significant adherence issues—over a million people monthly discontinue these medications due to side effects like nausea, muscle loss, and concerns about long-term safety from super-physiologic dosing. He discusses how microdosing these medications allows patients to find effective doses with fewer side effects and how resistance training is critical to prevent muscle loss during weight loss.
Thompson then describes his career trajectory developing minimally invasive endoscopic procedures as alternatives to surgery. He details the Endoscopic Sleeve Gastroplasty (ESG) procedure he developed in 2012, which folds the stomach to create a smaller pouch and suppress ghrelin production. He explains how this procedure targets specific mechanisms of obesity rather than just restricting calories. He also discusses newer approaches including fundal ghrelin cell ablation, small bowel procedures using magnetic anastomosis that increase GLP-1 production, and duodenal ablation to reset damaged intestinal tissue.
A major theme throughout is the importance of early metabolic screening before disease develops. Thompson advocates for continuous glucose monitors (CGMs) to catch glucose dysregulation early, measuring fasting insulin levels, calculating HOMA-IR scores for insulin resistance, and using tests like waist-to-height ratio and DEXA scans to detect ectopic fat accumulation. He describes the predictable sequence of metabolic dysfunction: calorie excess → glucose spikes → high fasting insulin → ectopic fat → insulin resistance → metabolic inflexibility → eventual diabetes and obesity.
Thompson discusses the concept of increased gut permeability ('leaky gut') as a real phenomenon backed by science, explaining how tight junctions become disorganized in people with metabolic dysfunction, allowing bacterial products like lipopolysaccharide (LPS) to cross into the bloodstream and trigger inflammation and insulin resistance.
The conversation covers diet recommendations, emphasizing adequate fiber intake, fermented foods like kimchi and kefir, resistance training, zone-2 cardio, and high-intensity interval training. Thompson explains why diet and exercise alone often fail due to the body's defended set point—the body fights weight loss through reduced gut hormone production, increased ghrelin, reduced metabolic rate, and increased muscle efficiency.
Finally, Thompson discusses cutting-edge treatments including gene therapy using viral vectors to inject GLP-1 genes into pancreatic beta cells using endoscopic ultrasound, allowing nutrient-responsive GLP-1 secretion. He also discusses how AI is being integrated into surgical and endoscopic procedures to provide real-time coaching, identify anatomical structures, and grade procedure quality objectively.
Throughout, Thompson emphasizes that effective treatment requires addressing underlying pathology rather than just managing symptoms, combining multiple therapeutic approaches rather than relying on single interventions, and starting treatment as early as possible before beta cell loss and peripheral nerve damage occur.
About this episode
Dr. Chris Thompson, MD, Professor of Medicine at Harvard Medical School, Chief of Interventional Gastroenterology at Mass General Brigham in Boston, and Co-Director of the Center for Weight Management and Wellness, is a world-renowned expert on gastroenterology, metabolism, nutrition, and obesity medicine. He explains how your GI tract regulates hunger, fullness, and blood sugar, as well as the gut microbiome, metabolic health, and weight loss. We also discuss common GI tract issues and which particular tests or interventions are actually useful. We discuss both GLP-1 medications and non-GLP-1 approaches to weight loss. Given that gut health is vital to all the organs of the body, overall health, and longevity, our discussion ought to be of interest and practical value to everyone, including, of course, those struggling with gut health or weight loss challenges. Show notes: https://go.hubermanlab.com/moMYULJ Thank you to our sponsors AG1: https://drinkag1.com/huberman Function: https://functionhealth.com/huberman Lingo: https://hellolingo.com/huberman LMNT: https://drinklmnt.com/huberman Our Place: https://fromourplace.com/huberman Timestamps 00:00:00 Dr. Chris Thompson 00:02:16 Digestive Tract, Gut Hormones & Nutrient Absorption 00:08:06 Colon Microbiome & Colon Cancer Screening 00:11:13 Sponsors: LMNT & Lingo 00:13:40 Swallowing Problems & Zenker’s Diverticula 00:16:08 Bowel Movements & Constipation 00:18:28 Fiber, Resistant Starch & the Gut Barrier 00:21:50 Intermittent Fasting & the Gut Microbiome 00:23:38 Fermented Foods, Microbial Diversity & Butyrate 00:27:12 H. pylori, Stress & Stomach Ulcers 00:30:20 GLP-1 Medications: Benefits & Limitations 00:33:42 Lower GLP-1 Doses, Weight Regain & Muscle Loss 00:37:35 GLP-1 Side Effects, Food Noise & Apathy 00:39:49 Bariatric Surgery & Medical Innovation 00:46:07 Sponsor: AG1 00:47:44 Hunger & Satiety: Ghrelin, CCK, GIP & GLP-1 00:50:01 Retatrutide & Combining Hormonal Targets 00:52:55 Ultra-Processed Foods, Overeating & Leptin 00:55:32 Incretin Discovery, Exendin-4 & the Gila Monster 00:59:35 Endoscopic Ultrasound & Pancreatic Biopsy 01:07:40 Early Metabolic Markers, CGMs & Fasting Insulin 01:13:06 Insulin Resistance & Metabolic Flexibility 01:15:53 Sponsor: Function 01:17:35 Patient Data, Screening & Treatment Adoption 01:26:31 AI, Robotics & Improving Procedures 01:29:27 Choosing a Surgeon & Measuring Procedure Quality 01:35:29 Image Guidance & Hyperspectral Imaging 01:37:19 Sponsor: Our Place 01:38:56 Diagnostics & Targeted Metabolic Treatments 01:42:45 Gastric Bypass, Foregut Exclusion & Diabetes 01:47:59 Duodenal Liners & Mucosal Resurfacing Research 01:52:58 Gut Permeability, Inflammation & Fatty Liver 01:59:39 Artificial Sweeteners, Fructose, Fats & Omega-3s 02:05:00 Resistance Training, Zone 2 Cardio & Intervals 02:06:31 Weight Set Point & Metabolic Adaptation 02:08:13 Endoscopic Sleeve Gastroplasty & Fundus Ablation 02:10:30 Magnetic Intestinal Connections & Combined Treatments 02:16:52 GLP-1 Gene Therapy Research 02:22:13 Innovation, Problem Solving & Teamwork 02:25:58 Zero-Cost Support, Sponsors & Neural Network Newsletter #hubermanlab #science #guthealth Disclaimer & Disclosures: https://www.hubermanlab.com/disclaimer
Key Insights
- Thompson states that if people don't feed their microbiome with fiber, the bacteria will consume the protective mucous layer of the intestines, leading to loss of butyrate production needed to maintain tight junctions, creating a 'snowball effect' of gut dysfunction
- Over a million people per month discontinue GLP-1 medications, with approximately 30% stopping in the first month and 50% by year-end, with primary issues being nausea during dose escalation, muscle loss, and concerns about long-term effects of super-physiologic dosing
- When GLP-1 medications are discontinued and weight returns, patients regain fat but not lean muscle, shifting body composition unfavorably with each cycle of on-off medication use, making microdosing or bridging procedures essential
- Thompson developed the Endoscopic Sleeve Gastroplasty (ESG) procedure in 2012 which folds the stomach to augment stretch receptors (making patients feel full faster) and suppress ghrelin by prolonging gastric emptying, achieving these effects through a minimally invasive mouth-based procedure
- Research on overfed mice versus controls shows that overfeeding causes intestinal villi to grow longer and heavier, upregulating the ability to absorb calories, with similar adaptation found in humans with obesity where villi are longer, tissue is thicker, and inflammatory cells are elevated eightfold
- Thompson advocates for checking fasting insulin levels (via White Hall 2 study data showing it predicts diabetes 10-15 years earlier than A1C) and using continuous glucose monitors to detect glucose dysregulation before it progresses to the next stage of metabolic disease
- Less than one-third of lean people are metabolically healthy based on metabolic parameters, and only 12% of the entire population is metabolically healthy, indicating that visible leanness does not guarantee metabolic health
- Thompson describes increased gut permeability as proven through studies showing that in MASH patients, tight junction proteins are downregulated at the transcriptional level and tracers like chromium-51 EDTA penetrate the intestinal barrier at much higher rates than in healthy controls
- GLP-1 medications achieve super-physiologic dosing (thousandfold increases over natural levels) rather than modest two- to four-fold increases, bathing tissues in the hormone in ways that never occurred in human history before
- Thompson's clinical observation of closing a gastric bypass fistula between the small pouch and remnant stomach led to immediate diabetes reversal in his patient, sparking his interest in understanding how specific anatomical/hormonal mechanisms drive metabolic dysfunction
- Animal studies showed that excluding the duodenum (foregut exclusion) significantly improved glucose tolerance in diabetic rats, while bypassing food to the distal gut without foregut exclusion showed no benefit, suggesting foregut exclusion is mechanistically important
- The Big Loser study follow-up found participants burned 500 fewer calories per day after weight loss, with the body reducing metabolic rate, downregulating satiety hormones like GLP-1 and PYY, increasing ghrelin, and making muscles 25% more efficient to defend against weight loss
- Thompson is involved in developing gene therapy using viral vectors to inject the GLP-1 gene into pancreatic beta cells via endoscopic ultrasound, allowing nutrient-responsive GLP-1 secretion from the source where it's needed rather than as a super-physiologic drug
- AI is now being integrated into endoscopic and surgical procedures to provide real-time coaching, identify blood vessels and anatomical structures by color-coding, count sutures, and grade procedure quality objectively by measuring metrics like full-thickness suture percentage and stomach volume reduction
- Thompson argues that effective long-term weight loss treatment requires addressing underlying metabolic dysfunction and behavioral/dietary patterns, not just using medications or procedures alone, as all treatments fail if patients don't address the fundamentals that caused the problem initially
Topics
Transcript
[0:00] There's all sorts of evidence that if you don't have a lot of fiber, your microbiome is not healthy. Feed your microbes. You know, they need to be fed. And what they eat is fiber. Okay? That's what you want to eating. You want them eating fiber. >> And if you're not feeding them fiber, they'll eat your mucous layer. Okay? And we already talked about how thin that barrier is. And all of a sudden, they start eating your mucous layer. They're they're not producing the butyrate you need. And the butyrates needed to maintain the tight junctions, right? So, there's layers to this. It's like a snowball effect that if you're not feeding those micro the microbiome…
Full transcript available for MurmurCast members
Sign Up to AccessMore from Andrew Huberman
Essentials: How to Assess & Improve All Aspects of Your Fitness | Dr. Andy Galpin
Dr. Andy Galpin outlines nine major physiological adaptations from exercise (skill, speed, power, strength, hypertrophy, muscular endurance, anaerobic capacity, VO2 max, and long-duration endurance) and provides specific, cost-effective assessment protocols and standards for each. He emphasizes that optimal fitness requires testing all nine areas annually to identify performance bottlenecks and guide training priorities.
The Art of True Happiness | Dr. Arthur Brooks
Dr. Arthur Brooks discusses the three macronutrients of happiness—enjoyment, satisfaction, and meaning—explaining how they differ from pleasure and how understanding them can transform one's life. He emphasizes that happiness necessarily includes unhappiness and suffering, and that true fulfillment comes from moral aspiration aligned with animal impulses, not from chasing worldly idols like money, power, pleasure, or honor.
Essentials: How to Access Your Creativity | Rick Rubin
Rick Rubin discusses how creativity operates like clouds and dreams—ephemeral and non-linear—and emphasizes that accessing creativity requires presence, attention to emerging ideas, and trusting subconscious processes rather than forcing or overthinking. He outlines a four-phase creative process (seed collecting, experimentation, crafting, completion) and explains how children maintain creative purity by operating without preconceived rules or expectations.
Essentials: The Science of Learning & Speaking Languages | Dr. Eddie Chang
Dr. Eddie Chang, a neurosurgeon and neuroscientist, discusses the distinction between speech and language, the neurobiology behind speech production, and his groundbreaking brain-machine interface work enabling paralyzed patients to communicate. He also addresses stuttering, neural augmentation ethics, and the future of avatar-based communication.
How to Overcome Social Anxiety | Dr. Nick Epley
Dr. Nick Epley, a behavioral scientist at the University of Chicago, discusses the science of social connection with Andrew Huberman, revealing that people systematically underestimate how positively strangers will respond to them. The conversation covers anthropomorphism, the benefits of everyday micro-interactions, social anxiety treatment through exposure therapy, and Epley's personal experience adopting a daughter with Down syndrome. Epley argues that small, habitual social connections throughout daily life are foundational to mental and physical well-being.